Missy Heidelberg
Head, Bioethics Takeda
Missy Heidelberg is the Global Head of Bioethics at Takeda, where she develops practical ethical frameworks for bioethics and responsible innovation across the drug development lifecycle. With 25+ years of experience, she is committed to advancing science for better health while upholding its ethical obligations to patients and society
Seminars
Wednesday 24th March 2027
Panel: Building Ethical Frameworks for Post-Trial Responsibilities
3:00 pm
- Understanding post-trial ethical responsibilities across drug development
- Frameworks for continued access to investigational medicines and devices
- Navigating unexpected, early discontinuations to ensure regulatory requirements and post-trial ethical obligations are met
- Key lessons learned from implementing frameworks, evaluation processes, and governance structures within a large organization
